A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells

Blood

Volumn 123, Issue 14, 2014, Pages 2199-2203

  Dubois, Sonia M ^a,b,c   Alexia, Catherine ^a,b,c   Wu, Youtong ^d   Leclair, Hélöise M ^e,f,g   Leveau, Claire ^a,b,c   Schol, Emilie ^a,b,c   Fest, Thierry ^f,h,i   Tarte, Karin ^f,h,i,j   Chen, Zhijian J ^d   Gavard, Julie ^e,f,g   Bidère, Nicolas ^a,b,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Equipe Labellisée Ligue Nationale Contre le Cancer   (France)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSERM   (France)

^g CNRS   (France)

^h UNIVERSITÉ DE RENNES 1   (France)

ⁱ ETABLISSEMENT FRANÇAIS DU SANG   (France)

^j RENNES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINEAR UBIQUITIN CHAIN ASSEMBLY COMPLEX; LYMPHOCYTE ANTIGEN RECEPTOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UBIQUITIN;

ARTICLE; CATALYSIS; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LARGE CELL LYMPHOMA; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOMA CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; CHEMISTRY; JURKAT CELL LINE; LYMPHOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; PROTEIN DOMAIN; TUMOR CELL LINE; UBIQUITINATION;

CATALYSIS; CELL LINE, TUMOR; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; LYMPHOMA; NF-KAPPA B; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, ANTIGEN, T-CELL; UBIQUITIN; UBIQUITINATION;

EID: 84899101931     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-05-504019     Document Type: Article

References (25)

1. Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med. 2010;362(15):1417-1429.
2. Shaffer AL III, Young RM, Staudt LM. Pathogenesis of human B cell lymphomas. Annu Rev Immunol. 2012;30:565-610.
3. Bidère N, Ngo VN, Lee J, et al. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 2009;458(7234):92-96.
4. Ferch U, Kloo B, Gewies A, et al. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2009;206(11):2313-2320.
5. Hailfinger S, Lenz G, Ngo V, et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2009;106(47):19946-19951.
6. Ngo VN, Davis RE, Lamy L, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 2006;441(7089):106-110.
7. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol. 2011;12(8):695-708.
8. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell. 2004;14(3):289-301. (Pubitemid 38591401)
9. Wu CJ, Ashwell JD. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation. Proc Natl Acad Sci U S A. 2008;105(8):3023-3028. (Pubitemid 351723661)
10. Israël A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol. 2010;2(3):a000158.
11. Emmerich CH, Schmukle AC, Walczak H. The emerging role of linear ubiquitination in cell signaling. Sci Signal. 2011;4(204):re5.
12. Damgaard RB, Nachbur U, Yabal M, et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell. 2012;46(6):746-758.
13. Gerlach B, Cordier SM, Schmukle AC, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 2011;471(7340):591-596.
14. Haas TL, Emmerich CH, Gerlach B, et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell. 2009;36(5):831-844.
15. Ikeda F, Deribe YL, Skånland SS, et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature. 2011;471(7340):637-641.
16. Tokunaga F, Nakagawa T, Nakahara M, et al. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature. 2011;471(7340):633-636.
17. Niu J, Shi Y, Iwai K, Wu ZH. LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO J. 2011;30(18):3741-3753.
18. Boisson B, Laplantine E, Prando C, et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol. 2012;13(12):1178-1186.
19. Tokunaga F, Sakata S, Saeki Y, et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol. 2009;11(2):123-132.
20. Emmerich CH, Ordureau A, Strickson S, et al. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc Natl Acad Sci U S A. 2013;110(38):15247-15252.
21. Fiil BK, Damgaard RB, Wagner SA, et al. OTULIN restricts Met1-linked ubiquitination to control innate immune signaling. Mol Cell. 2013;50(6):818-830.
22. Sasaki Y, Sano S, Nakahara M, et al. Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. EMBO J. 2013;32(18):2463-2476.
23. Matsumoto ML, Dong KC, Yu C, et al. Engineering and structural characterization of a linear polyubiquitin-specific antibody. J Mol Biol. 2012;418(3-4):134-144.
24. Keusekotten K, Elliott PR, Glockner L, et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell. 2013;153(6):1312-1326.
25. Liu S, Chen J, Cai X, et al. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife. 2013;2:e00785.